Skip to main content
Cancer Explained
Donate
Beginner 5 min readEditorial review complete

Adriamycin (Doxorubicin): What It Is and What to Expect

Adriamycin (Doxorubicin) is a type of chemotherapy called an anthracycline used to help treat breast cancer, lymphomas, and other cancers.

NCI source

National Cancer Institute — Doxorubicin Hydrochloride

A woman in a headscarf receives an IV infusion while a nurse attends her
A woman in a headscarf receives an IV infusion while a nurse attends her

Key fact

Adriamycin is the brand name; its generic name is doxorubicin.

The short answer

Adriamycin (Doxorubicin) is a type of chemotherapy called an anthracycline. It damages the DNA inside cancer cells and blocks an enzyme they need to grow, causing the cells to die. It is used to help treat breast cancer, lymphomas, leukemias, and other cancers, and is usually given as an IV infusion. Like all cancer medicines it can cause side effects; this page explains the common ones and the warning signs to report. It is educational only and not a substitute for your care team's advice.

  • Adriamycin is the brand name; its generic name is doxorubicin.

  • It is a type of chemotherapy called an anthracycline — it damages the DNA inside cancer cells and blocks an enzyme they need to grow, causing the cells to die.

  • It is used to help treat breast cancer, lymphomas, leukemias, and several other cancers.

  • It is usually given as an IV infusion.

Choose how you want to understand this

The full explanation.

The red drug, and the red urine

Doxorubicin is bright red in the syringe. For a day or two afterwards your urine, and sometimes your tears and sweat, turn pink or orange. That is the dye leaving your body. It is harmless, it is expected, and it is not blood. Knowing this in advance saves a frightening trip to the bathroom.

Adriamycin is a brand name for it. Most hospitals now use the generic name. It is an anthracycline: it slips between the strands of DNA and jams the enzyme a cell needs to untangle them, so the cell cannot divide.

The cancers on its label

One approved use is after breast cancer surgery, as part of a multi-drug plan, for women whose armpit lymph nodes were involved.

The rest of the label covers treatment of acute lymphoblastic leukemia, acute myeloblastic leukemia, Hodgkin lymphoma, non-Hodgkin lymphoma, and a long list of cancers that have spread: breast, Wilms' tumor, neuroblastoma, soft tissue sarcoma, bone sarcoma, ovarian, transitional cell bladder, thyroid, gastric, and bronchogenic carcinoma of the lung.

A different product, liposomal doxorubicin, wraps the same drug in tiny fat bubbles. It behaves differently and has its own label. Check which one you are having.

A lifetime limit set by your heart

Doxorubicin can weaken heart muscle, and the risk depends on how much you have had in total across your whole life. The label describes it as a curve: low single digits at the cumulative totals most treatment plans reach, climbing steeply toward the highest lifetime totals. Other heart-toxic treatments, including chest radiation, push it higher. Your team tracks your lifetime total — it is one of the numbers worth asking for and keeping in your own records, because it follows you between hospitals for the rest of your life.

This is why your team measures heart pumping function before treatment, during it, and afterwards, usually with an echocardiogram or a MUGA scan. It is also why your total dose is tracked in your record. Damage can appear years later, so tell any future doctor that you have had an anthracycline. Report breathlessness, ankle swelling, a racing or irregular heartbeat, or being unable to lie flat.

Why the drip site is watched so closely

If doxorubicin leaks out of the vein into surrounding tissue, it destroys it. The label describes injury bad enough to need the area cut out and skin grafted. Treatment is stopped instantly and ice applied.

So say something the moment you feel burning, stinging or pain at the drip site, or notice swelling or redness. Do not wait to be sure. Many people receive it through a central line or port for this reason.

Second cancers and other late effects

Leukemia and myelodysplastic syndrome occur more often after anthracycline treatment. That risk is real but small, and it is weighed against the cancer being treated now.

Blood counts fall hard, and the label calls the myelosuppression severe, with infection and septic shock among the possible outcomes. Mouth sores are common. Nausea and hair loss are common. Doxorubicin can also make radiation effects worse, including a flare-up in a previously treated area.

What to report between cycles

Not everything on this list moves at the same speed.

  • Call 911 or go to an emergency department if you have breathlessness at rest, chest pain, a pounding or irregular heartbeat, wake up unable to lie flat, or have bleeding you cannot stop.
  • Call your cancer team straight away, day or night, if your temperature reaches 38C (100.4F), or you get shaking chills. CDC treats a fever during chemotherapy as a medical emergency, because doxorubicin can leave you with too few white cells to contain an infection. If they cannot be reached quickly, go to an emergency department and tell them you are having chemotherapy.
  • Tell the nurse immediately, during the infusion, if you feel burning, stinging or pain at the drip site, or see swelling or redness. The drip is stopped on the spot. If pain, swelling or blistering appears at that site in the days afterwards, call your team the same day.
  • Call your care team the same day if mouth ulcers stop you eating or drinking, your ankles are swelling, or you notice unusual bruising, nosebleeds, or blood in your urine or stool.
  • Call your care team within a day or two if you are more breathless than usual on stairs, or newly tired in a way that is not lifting.

Sources

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1fd148fb-0fbc-4b6f-b790-23546fb46a71

https://www.cancer.gov/about-cancer/treatment/drugs/doxorubicinhydrochloride

https://www.cdc.gov/cancer-preventing-infections/patients/fever.html

Words to know

Tap any term to see what it means.

Browse the full glossary →

An older woman sits at a kitchen table reading a document with coffee

Common questions

What is Adriamycin?

Adriamycin (Doxorubicin) is a type of chemotherapy called an anthracycline. It damages the DNA inside cancer cells and blocks an enzyme they need to grow, causing the cells to die. It is used to help treat breast cancer, lymphomas, leukemias, and several other cancers.

How is Adriamycin given?

It is usually given as an IV infusion. It is given as an intravenous (IV) infusion — a slow drip into a vein — at a clinic or hospital, usually repeated on a schedule of cycles with rest periods in between. The exact schedule is set by your care team.

What are the common side effects of Adriamycin?

Commonly reported side effects include nausea, hair loss, mouth sores, low blood counts, and temporary reddish urine. Not everyone gets them, and many can be managed. Tell your care team about anything new or worsening.

Does Adriamycin cure cancer?

That depends on the person, the cancer type, and its stage. For some people a medicine like this can control cancer for a long time or be part of a curative plan; for others the goal is to slow the cancer or ease symptoms. Your care team can explain the goal in your situation.

Questions to ask your doctor

Being prepared helps you get the most out of your appointments. Save or print these questions.

Open my question list

Tap a question to save it to your list (kept on this device).

Human Connection Layer

Speak With Trained Specialists & Human Navigators

Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.

Free & Confidential

Talk to a trained cancer information specialist

Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.

Contact your oncology team

Locate after-hours contact numbers, portal messages, or urgent triage phone lines.

Find a patient navigator

Get one-on-one help with appointments, logistics, translation, and care coordination.

Find a genetic counselor

Discuss inherited mutation risk, family history, and genetic testing options.

Find an oncology social worker

Access emotional counseling, family support groups, and mental health resources.

Find a financial navigator

Locate copay assistance foundations, grant programs, and lodging/travel support.

Find a clinical-trial specialist

Search matching studies and speak with NCI trial information specialists.

Get urgent help

Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.

Help Us Improve This Guide

Did this explanation answer your question and help you determine your next step?

Know someone who needs this?

Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.

Email itText itWhatsApp

Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.

Knowledge Check

0 of 2 answered

  1. Q1.What kind of medicine is Adriamycin?
  2. Q2.Which of these is Adriamycin used to help treat?

This self-assessment checks understanding of educational content only. It is not medical advice.

Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.

Sources last checked: 2026-08-13 what this meansLast updated: 2026-08-21Next planned review: 2027-01-14

How this page was created

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status — Editorial review complete. This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.

General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Our editorial processHow we use AIReport an error

How this page was created

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status: Editorial review complete This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Read more about our editorial process, our use of AI, and our corrections policy.

Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.

After using this page, do you understand what to do next?

Anonymous — we only record the answer, never who gave it.